How has MRNA's revenue growth performed historically?
MRNA's revenue has grown faster (712.68% per year) than the US Biotechnology industry average (141.1%)
MRNA's revenue has grown faster (712.68% per year) than the US market average (19.19%)
MRNA earnings and revenue history
Current Profit Margin
MRNA Return on equity
MRNA's Return on Equity (88.1%) shows a company that is highly efficient at transforming shareholder equity into returns
MRNA Return on assets
MRNA is generating higher Return on Assets (34.2%) than the US Biotechnology industry average (-4.15%)
MRNA Return on capital employed
MRNA earnings dates
Next earnings date
Oct 27, 2021
Moderna Earnings & Revenue FAQ
What were MRNA's earnings last quarter?
On Invalid Date, Moderna (NASDAQ: MRNA) reported Q2 2021 earnings per share (EPS) of $6.93, up 2,335.48% year over year. Total Moderna earnings for the quarter were $2.78 billion. In the same quarter last year, Moderna's earnings per share (EPS) was -$0.31.
What was MRNA's earnings growth in the past year?
As of Q3 2021, Moderna's earnings has grown null year over year. Moderna's earnings in the past year totalled $3.49 billion.
On Invalid Date, Moderna (NASDAQ: MRNA) reported Q2 2021 revenue of $4.35 billion up 6,398.51% year over year. In the same quarter last year, Moderna's revenue was $67.00 million.
What was MRNA's revenue growth in the past year?
As of Q3 2021, Moderna's revenue has grown 6,516.01% year over year. This is 5,564.21 percentage points higher than the US Biotechnology industry revenue growth rate of 951.81%. Moderna's revenue in the past year totalled $7.02 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.